USPTO trademark

XBALCI

RegisteredUSPTOWord markClass 5

"XBALCI" is a word mark owned by Glaxo Group Limited, filed at the USPTO on May 2, 2025. It is registered and covers class 5 (Pharmaceuticals).

View Glaxo Group Limited portfolioGet this data via the API
Official USPTO record
XBALCI trademark as filed
As filed with the USPTO
Status
Registered
Since January 6, 2026
Filed
May 2, 2025
Registered
January 6, 2026
Expires
Not recorded
Application no.
99166872
Registration no.
8093271
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns XBALCI

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Glaxo Group Limited

Stevenage, United Kingdom

19,383 trademarks in the portfolioView company

Representative

Elizabeth K. Rucki

GSK

Goods and services

What the mark covers

The products and services XBALCI is filed for, grouped by Nice class.

  • Vaccines; Anti-infectives; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Assigned to examiner
  8. New application office supplied data entered
  9. Application filing receipt mailed
  10. New application entered
FAQ

About XBALCI

Who owns the trademark "XBALCI"?

The USPTO trademark "XBALCI" (application 99166872) is owned by Glaxo Group Limited.

What is the status of "XBALCI"?

Its status at the USPTO is: registered.

When was "XBALCI" registered?

It was registered on January 6, 2026.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull XBALCI and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2abd-920e-71b3-af4a-41c82642c3cd
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2abd-920e-71b3-af4a-41c82642c3cd",
  "object": "trademark",
  "mark_text": "XBALCI",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "99166872",
  "filing_date": "2025-05-02",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Glaxo Group Limited",
      "entity_id": "ent_019eb6f6-4cb9-77ae-916f-63b3231a6d3d"
    }
  ]
}